AU568839B2 - Pharmaceutical imidazoles and hydro-pyrimidines and hydro-derivatives - Google Patents

Pharmaceutical imidazoles and hydro-pyrimidines and hydro-derivatives

Info

Publication number
AU568839B2
AU568839B2 AU24877/84A AU2487784A AU568839B2 AU 568839 B2 AU568839 B2 AU 568839B2 AU 24877/84 A AU24877/84 A AU 24877/84A AU 2487784 A AU2487784 A AU 2487784A AU 568839 B2 AU568839 B2 AU 568839B2
Authority
AU
Australia
Prior art keywords
compound
methyl
dihydro
formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU24877/84A
Other languages
English (en)
Other versions
AU2487784A (en
Inventor
Denis Mahlon Bailey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of AU2487784A publication Critical patent/AU2487784A/en
Application granted granted Critical
Publication of AU568839B2 publication Critical patent/AU568839B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/34—Monohydroxylic alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU24877/84A 1983-03-14 1984-02-23 Pharmaceutical imidazoles and hydro-pyrimidines and hydro-derivatives Ceased AU568839B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US475193 1983-03-14
US06/475,193 US4540705A (en) 1983-03-14 1983-03-14 Antidepressant imidazolines and related compounds

Publications (2)

Publication Number Publication Date
AU2487784A AU2487784A (en) 1984-09-20
AU568839B2 true AU568839B2 (en) 1988-01-14

Family

ID=23886585

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24877/84A Ceased AU568839B2 (en) 1983-03-14 1984-02-23 Pharmaceutical imidazoles and hydro-pyrimidines and hydro-derivatives

Country Status (16)

Country Link
US (1) US4540705A (enExample)
EP (1) EP0125410A3 (enExample)
JP (1) JPS59193875A (enExample)
KR (1) KR900001216B1 (enExample)
AU (1) AU568839B2 (enExample)
CA (1) CA1215369A (enExample)
DK (1) DK112984A (enExample)
ES (1) ES8601907A1 (enExample)
FI (1) FI840839A7 (enExample)
GR (1) GR81813B (enExample)
IL (1) IL70966A (enExample)
NO (1) NO840893L (enExample)
NZ (1) NZ207184A (enExample)
PH (1) PH19715A (enExample)
PT (1) PT78195B (enExample)
ZA (1) ZA841323B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016800D0 (en) * 1990-07-31 1990-09-12 Shell Int Research Tetrahydropyrimidine derivatives
DK1028110T3 (da) * 1997-10-02 2004-07-19 Daiichi Seiyaku Co Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf
US6559157B2 (en) 1997-10-02 2003-05-06 Daiichi Pharmaceutical Co., Ltd. Dihydronaphthalene compounds
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
EP0924209B1 (en) * 1997-12-19 2003-05-02 Eli Lilly And Company Hypoglycemic imidazoline compounds
EP1266897A3 (en) * 1997-12-19 2003-12-03 Eli Lilly And Company Hypoglycemic imidazoline compounds
US6410562B1 (en) 1998-12-18 2002-06-25 Eli Lilly And Company Hypoglycemic imidazoline compounds
FR2787451B1 (fr) * 1998-12-18 2001-01-26 Adir Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2637312A1 (en) * 2006-01-27 2007-08-02 F. Hoffmann-La Roche Ag Use of substituted 2-imidazole of imidazoline derivatives
MX2009003801A (es) 2006-10-19 2009-04-22 Hoffmann La Roche Aminometil-4-imidazoles.
BRPI0718054A2 (pt) 2006-11-02 2013-11-05 Hoffmann La Roche 2-imidazóis substituídos como moduladores de receptores associados à traços de aminas
AU2007321376A1 (en) 2006-11-16 2008-05-22 F. Hoffmann-La Roche Ag Substituted 4-imidazoles
WO2008071574A1 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
US7582691B2 (en) * 2007-01-17 2009-09-01 Sabic Innovative Plastics Ip B.V. Poly(arylene ether) compositions and articles
CA2675221C (en) 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Novel 2-aminooxazolines as taar1 ligands
MX2009008465A (es) 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
CA2691082A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
BRPI0812833A2 (pt) 2007-07-03 2014-12-09 Hoffmann La Roche 4-imidazolinas e seu uso como antidepressivos
KR101133862B1 (ko) 2007-07-27 2012-04-06 에프. 호프만-라 로슈 아게 Ｔａａｒ 리간드로서의 2-아제티딘메테인아민 및 2-피롤리딘메테인아민
CA2695331A1 (en) 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
RS60825B1 (sr) 2016-03-17 2020-10-30 Hoffmann La Roche Aktivnost derivata 5-etiol-4-metil-pirazol-3-karboksamida kao agonista taar-a

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU316036A (en) * 1936-08-04 1937-05-20 Thew. S. Tyler Company Screening apparatus
AU3564071A (en) * 1970-11-30 1973-05-17 CARLO ERBA Sp. A Imidazoline derivatives and process for their preparation
AU1082676A (en) * 1975-02-05 1977-08-11 Rohm And Haas Company Imidazole metal salt complexes and mixtures of imidazoles and metal salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2731471A (en) * 1956-01-17 Nxg hi
US2161938A (en) * 1934-07-31 1939-06-13 Soc Of Chemical Ind Imidazolines
FR926661A (fr) * 1941-07-09 1947-10-08 Lovens Kemiske Fabrik V Aug Ko Méthyle-imidazolines substituées et leur procédé de préparation
GB757650A (en) * 1953-06-15 1956-09-19 Pfizer & Co C Improvements in or relating to substituted imidazolines and the preparation thereof
DE1150180B (de) * 1962-04-12 1963-06-12 Merck Ag E Mittel zur Vorbehandlung der Haut fuer die Rasur

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU316036A (en) * 1936-08-04 1937-05-20 Thew. S. Tyler Company Screening apparatus
AU3564071A (en) * 1970-11-30 1973-05-17 CARLO ERBA Sp. A Imidazoline derivatives and process for their preparation
AU1082676A (en) * 1975-02-05 1977-08-11 Rohm And Haas Company Imidazole metal salt complexes and mixtures of imidazoles and metal salts

Also Published As

Publication number Publication date
KR840008327A (ko) 1984-12-14
PT78195A (en) 1984-04-01
ES530345A0 (es) 1985-11-16
JPS59193875A (ja) 1984-11-02
PT78195B (en) 1986-04-24
IL70966A (en) 1987-08-31
EP0125410A3 (en) 1987-01-14
EP0125410A2 (en) 1984-11-21
NZ207184A (en) 1986-12-05
US4540705A (en) 1985-09-10
FI840839A7 (fi) 1984-09-15
GR81813B (enExample) 1984-12-12
DK112984D0 (da) 1984-02-28
DK112984A (da) 1984-09-15
FI840839A0 (fi) 1984-03-02
PH19715A (en) 1986-06-17
AU2487784A (en) 1984-09-20
IL70966A0 (en) 1984-05-31
KR900001216B1 (ko) 1990-02-28
CA1215369A (en) 1986-12-16
ES8601907A1 (es) 1985-11-16
ZA841323B (en) 1984-10-31
NO840893L (no) 1984-09-17

Similar Documents

Publication Publication Date Title
AU564963B2 (en) N-alkoxyaminosulfonyl-ureas and n-alkyl- sulfonylaminosulfonylureas
AU580262B2 (en) Drug administration
AU576753B2 (en) Catheter
AU2487784A (en) Pharmaceutical imidazoles and hydro-pyrimidines and hydro-derivatives
AU2593784A (en) Pharmaceutical ergocalciferols and intermediates
GR80788B (en) Drug preparations
AU570601B2 (en) Puriifying blood and plasma
AU2714284A (en) Self-disintegrating tablet
GB8306264D0 (en) Pharmaceutical preparations
AU2636384A (en) Phenylaminobenzenealkanols and preparation
AU3622284A (en) Catheter
AU528710B2 (en) Hexahydro-trans and tetrahydropyridoindole
AU1977583A (en) Fungicidal triazalyl and imidazalyl t-butanols
AU569529B2 (en) Rooperol and derivatives
AU2561984A (en) Human interferon- polypeptide
AU2361184A (en) Disubstituted 6-penicillins and 7-cephalosporins
AU563979B2 (en) Pharmaceutical azolylmethylcycloalkanes
AU3503684A (en) Human calcitonin-gene-related-peptide
PH21920A (en) Hydantoin derivatives and medicine containing the same
AU573272B2 (en) Dihydroisoquinolines and tetrahydroisoquinolones
AU3601684A (en) Pyrid-4-one and quinilone derivatives
AU1898983A (en) Perfluoroalkylmaleinamides and perfluoroalkylfumaramides
AU574081B2 (en) Mini - somatostatins
AU568385B2 (en) Pyrrolizinones and indolizinones
GB8419863D0 (en) Pharmaceutical preparations